Edwards Lifesciences Corporation EW
Set alert
92.01 USD -2.43 -2.57%
At close · Oct 30
92.01 0.00 0.00%
After hours · Oct 30, 6:00 PM ET
91.87 Day range 95.34
75.87 52-week range 95.18
- YTD
- +7.93%
- 1 year
- +10.22%
- Open
- 94.55
- Prev close
- 94.44
- Mkt cap
- 53.03B
- Vol
- 6.04M
- Avg vol
- 3.30M
- EPS
- 1.68
- P/E
- 54.77
- Div yield
- 0.00%
More statistics
- Low
- 91.87
- High
- 95.34
- Forward P/E
- 27.19
- Beta
- 0.86
- Short ratio
- 2.43
- Inst. own
- 95.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 88.10
- 200-d avg
- 85.38
- 1y target
- 101.87
1Y chart
Events in this range
- Feb 10, 2026Earnings: 0.58; estimate 0.618; surprise -6.15%
- Apr 23, 2026Earnings: 0.78; estimate 0.729; surprise 7%
- Jul 16, 2026Rating: Truist Securities · Hold → Hold
- Jul 23, 2026Earnings: 0.78; estimate 0.743; surprise 4.98%
- Jul 24, 2026Rating: Piper Sandler · Overweight → Overweight
- Jul 24, 2026Rating: JP Morgan · Overweight → Overweight
- Jul 24, 2026Rating: Leerink Partners · Market Perform → Outperform
- Sep 11, 2026Rating: BTIG · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Overweight
Signals (73)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 14, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Sep 30, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 29, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Sep 17, 2026 | 1 month ago |
| SMA: Bullish | Sep 16, 2026 | 1 month ago |
| SMA: Bullish | Sep 14, 2026 | 1 month ago |
| SMA: Bearish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 8, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 21, 2026 | 2 months ago |
| SMA: Bullish | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 3 months ago |
| SMA: Bullish | Jul 28, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 17, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 24, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bullish | May 13, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | May 8, 2026 | 5 months ago |
| SMA: Bullish | Apr 30, 2026 | 6 months ago |
| SMA: Bearish | Apr 29, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| SMA: Bullish | Apr 24, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bearish | Apr 23, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bullish | Apr 22, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bearish | Apr 21, 2026 | 6 months ago |
| SMA: Bullish | Apr 20, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 20, 2026 | 6 months ago |
| SMA: Bullish | Apr 17, 2026 | 6 months ago |
| SMA: Bearish | Apr 9, 2026 | 6 months ago |
| SMA: Bullish | Apr 1, 2026 | 7 months ago |
| SMA: Bearish | Mar 27, 2026 | 7 months ago |
| SMA: Bearish | Mar 26, 2026 | 7 months ago |
| SMA: Bullish | Mar 25, 2026 | 7 months ago |
| SMA: Bearish | Mar 23, 2026 | 7 months ago |
| SMA: Bullish | Mar 20, 2026 | 7 months ago |
| SMA: Bearish | Mar 19, 2026 | 7 months ago |
| SMA: Bullish | Mar 16, 2026 | 7 months ago |
| SMA: Bearish | Mar 13, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 13, 2026 | 7 months ago |
| SMA: Bullish | Mar 9, 2026 | 7 months ago |
| SMA: Bearish | Mar 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 25, 2026 | 8 months ago |
| SMA: Bullish | Feb 20, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 19, 2026 | 8 months ago |
| RSI: Oversold | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| SMA: Bearish | Jan 22, 2026 | 9 months ago |
| SMA: Bullish | Jan 21, 2026 | 9 months ago |
| SMA: Bearish | Jan 12, 2026 | 9 months ago |
| SMA: Bullish | Jan 9, 2026 | 9 months ago |
| SMA: Bearish | Jan 8, 2026 | 9 months ago |
| SMA: Bullish | Jan 6, 2026 | 9 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| MACD: Sell Signal | Dec 31, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 23, 2025 | 10 months ago |
| MACD: Sell Signal | Nov 20, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
| RSI: Overbought | Nov 3, 2025 | 12 months ago |
Key statistics
- Market cap
- 52.92B
- Enterprise value
- 50.99B
- Trailing P/E
- 54.71
- Forward P/E
- 27.19
- PEG ratio
- 1.98
- Price / sales
- 8.13
- Price / book
- 4.99
- EPS (TTM)
- 1.68
- Beta
- 0.86
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.43%
- Revenue (TTM)
- 6.51B
- Revenue growth
- 13.60%
- Free cash flow
- 1.23B
- Total cash
- 4.25B
- Total debt
- 704.40M
- Return on equity
- 9.18%
- Shares outstanding
- 575.80M
- Short % of float
- 1.84%
- 50-day average
- 88.10
- 200-day average
- 85.38
Analyst view
Consensus: buy
Buy
Price target (mean) 101.87 +10.7% upside
Now 92.01
- Target (low)
- 84.00
- Target (mean)
- 101.87
- Target (high)
- 117.00
Ratings (0m) 30 23 buy · 7 hold · 0 sell
- Strong buy5
- Buy18
- Hold7
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.73653.
Financials — quick view
EW Revenue — quarterly 1.74B
EW Net income — quarterly 241.90M
EW EPS — quarterly 0.42
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.737 | — | — | — |
| Jul 23, 2026 | Jun 30, 2026 | 0.743 | 0.78 | +0.04 | +4.98% |
| Apr 23, 2026 | Mar 31, 2026 | 0.729 | 0.78 | +0.05 | +7.00% |
| Feb 10, 2026 | Dec 31, 2025 | 0.618 | 0.58 | -0.04 | -6.15% |
| Oct 30, 2025 | Sep 30, 2025 | 0.596 | 0.67 | +0.07 | +12.42% |
| Jul 24, 2025 | Jun 30, 2025 | 0.624 | 0.67 | +0.05 | +7.37% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 7, 2026 | Barclays | init | — | Overweight |
| Sep 11, 2026 | BTIG | reit | Buy | Buy |
| Jul 24, 2026 | Leerink Partners | up | Market Perform | Outperform |
| Jul 24, 2026 | JP Morgan | main | Overweight | Overweight |
| Jul 24, 2026 | Piper Sandler | reit | Overweight | Overweight |
| Jul 16, 2026 | Truist Securities | main | Hold | Hold |
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. It distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- edwards.com
News
- Edwards' Q3 Earnings on the Horizon: What's in the Cards?
- Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key Metrics
- Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio Thrives
- $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
- Is This the Right Time to Hold EW Stock in Your Portfolio?
- FDA Approval of Edwards Lifesciences' PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve Disease
- Is EW Overvalued? DCF Says Worth $40
- 9 Health Care Stocks Whale Activity In Today’s Session
- Edwards Lifesciences Corporation $EW Stock: Birch Hill Investment Advisors LLC Trims Position
- First Citizens Bank & Trust Co. Makes New $792,000 Investment in Edwards Lifesciences Corporation $EW
Your note
Sign in to keep a note on EW — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOBO DONALD E JR | Officer | Sale | May 26, 2026 | 0 |
| CHOPRA DAVEEN | Officer | Sale | Aug 25, 2026 | 44,324 |
| GALLAHUE KIERAN T. | Director | Stock Award(Grant) | May 7, 2026 | 83,971 |
| LIPPIS DANIEL J | Officer | Sale | Oct 7, 2026 | 40,033 |
| LORANGER STEVEN R | Director | Stock Award(Grant) | May 7, 2026 | 84,369 |
| MISTRAS THEODORA | Chief Financial Officer | Stock Award(Grant) | Jul 8, 2026 | 99,920 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 10.21% | 58,789,433 | 5.40B | Jun 29, 2026 |
| Vanguard Capital Management LLC | 6.53% | 37,615,952 | 3.46B | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 4.59% | 26,411,402 | 2.43B | Jun 29, 2026 |
| State Street Corporation | 4.57% | 26,321,940 | 2.42B | Jun 29, 2026 |
| JPMORGAN CHASE & CO | 3.96% | 22,783,175 | 2.09B | Jun 29, 2026 |
| Wellington Management Group, LLP | 2.92% | 16,827,967 | 1.55B | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 18,279,615 | 1.68B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | 2.59% | 14,919,502 | 1.37B | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Mid-Cap Index Fund | 2.17% | 12,476,018 | 1.15B | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.97% | 11,357,910 | 1.04B | Jul 30, 2026 |
| iShares Trust-iShares Core S&P 500 ETF | 1.33% | 7,683,257 | 706.17M | Sep 29, 2026 |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | 1.30% | 7,474,400 | 686.97M | Aug 30, 2026 |